Bactiguard’s CEO Anders Göransson speaks with excitement about the future of the company and the growth journey that lays ahead. “Hearing the great feedback from our partners and patients makes me realise that I made the right choice to join Bactiguard”, says Anders Göransson.
Read the interview where Anders Göransson shares his thoughts on where he sees the company heading and what he thinks makes a great leader.
Bactiguard Holding AB (publ) published the interim report for the third quarter on Thursday October 28, 2021 at 8:00 CET.
The Bactiguard technology reduces microbial adhesion to the surface of medical devices, which decreases the risk of biofilm formation leading to infection.
